Skip to main content

When the Mind Does Not Work as It Should

  • Chapter
  • First Online:
Book cover Biochemistry for Anesthesiologists and Intensivists

Abstract

The authors consider the possible correlations between certain alterations of the neurotransmitters of the central nervous system and two common clinical syndromes: schizophrenia and depression.

Psychic life is not an abstract world which lives of itself, but rather a set of activities tightly bound to the life of the organism, which are subject to the influence of the latter and in turn affect the activity of the organic functions.

Mario Gozzano

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Afro Publio Terenzio. Phormio. (160 a. C.) Atto IV, scena prima, 9.

    Google Scholar 

  2. Eugen B. Dementia praecox, oder Gruppe der Schizophrenien. Leipzig: Duticke Verlag; 1911.

    Google Scholar 

  3. Herman W. The Caine Mutiny. New York: Doubleday Publisher; 1951.

    Google Scholar 

  4. Aiazzi Mancini M, Donatelli L. Trattato di farmacologia. Milano: Francesco Vallardi Editore; 1969.

    Google Scholar 

  5. Bernsohn J, Namajuk J, Cchrane LS. Inhibition of brain cytochrome oxidase and ATP-ase by chloropromazine analogues. Proc Soc Exp Biol Med. 1956;92:201–3.

    Article  CAS  PubMed  Google Scholar 

  6. Laborit H. Les Régulations metaboliques. Paris: Masson & Cie Editeurs; 1965.

    Google Scholar 

  7. Laborit H, Huguenard P, Allaume R. Un nouvou stabilisateurr vegetatif : le 4560 RP (chloropromazine). Presse méd. 1952;60(10):206–8.

    CAS  PubMed  Google Scholar 

  8. Bear MF, Connors BW, Paradiso MA. Neuroscience: exploring the brain—third edition. New York: Lippincot Williams & Wilkins; 2007.

    Google Scholar 

  9. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology. 1989;99(1., Supplement):S18–27.

    Article  PubMed  Google Scholar 

  10. https://en.wikipedia.org/wiki/Phencyclidine

  11. Coyle JT, et al. Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia. Dialogues Clin Neurosci. 2010;12(3):359–82.

    PubMed  PubMed Central  Google Scholar 

  12. Kartvelishvily E, Shleper M, et al. Neuronderived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors. J Biol Chem. 2006;281:14151–62.

    Article  CAS  PubMed  Google Scholar 

  13. Caulfield MP, Birdsall NJ. International Union of Pharmacology, XVII. Classification of muscarinic receptors. Pharmacol Rev. 1998;50:279–90.

    CAS  PubMed  Google Scholar 

  14. Shekhar A, Potter WZ, Lightfoot J, et al. Selective muscarinic receptors agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry. 2008;165:1033–9.

    Article  PubMed  Google Scholar 

  15. Figiel G, Sadowsky C. A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurologic disorders. Curr Med Res Opin. 2008;24:157–66.

    Article  CAS  PubMed  Google Scholar 

  16. Grossberg GT. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia; review of neuropsychiatric impairment in Alzheimer’s disease. Curr Med Res Opin. 2005;21:1631–9.

    Article  CAS  PubMed  Google Scholar 

  17. Dean B, McLeod M, Keriakous D, McKenzie J, Scarr E. Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2002;7:1083–91.

    Article  CAS  PubMed  Google Scholar 

  18. KSP A, Höglund AU. Intravenously administered oxotremorine and atropine, in doses known to affect pain threshold, affect the intraspinal release of acetylcholine in rats. Pharmacol Toxicol. 2002;90:187–92.

    Article  Google Scholar 

  19. Bartolini A, Ghelardini C, Fantetti L, et al. Role of muscrinic receptor subtypes in central antinoception. Br J Pharmacol. 1992;105:77–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Baba H, et al. Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol. 1998;508:83–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yegin A, Yilmaz M, Karsli B, Erman M. Analgesic effects of intrathecal neostigmine in perianal surgery. Eur J Anaesthesiol. 2003;20:404–8.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta S. Postoperative analgesia with intrathecal neostigmina; two 75 mcg and 50 mcg with heavy bupivacaine. Internet J Anesthesiol. 2008;25:1.

    Google Scholar 

  23. Kaya FN, Sahin S, Owen MD, Eisenach JC. Epidural neostigmine produces analgesia but also sedation in women after caesarean delivery. Anesthesiology. 2004;100:381–5.

    Article  CAS  PubMed  Google Scholar 

  24. Lauretti GE, De Oliveira R, Reis MP, et al. Study of three different doses of epidural neostigmina coadministered with lidocaine for postoperative analgesia. Anesthesiology. 1999;90(6):1534–8.

    Article  CAS  PubMed  Google Scholar 

  25. Buaziz H, Paqueron X, Bur ML, Merle M, Laxenaire MC, Benhamou D. No enhancement of sensory and motor blockade by neostigmine added to mepivacaina axillary plexus. Anesthesiology. 1999;91(1):78–83.

    Article  Google Scholar 

  26. Alemanno F, Ghisi D, Westermann B, Bettoni A, Fanelli A, LaColla L, Danelli G, Cesana BM. The use of vitamin B1 as a perineural adjuvant to the Middle Interscalene Block for postoperative analgesia after shoulder surgery. Acta Biomed. 2016;87(1):22–7.

    PubMed  Google Scholar 

  27. Kumary V, Postma V. Nicotine use in schizophrenia: the self-medication hypothesis. Neurosci Biobehav Rev. 2005;6(29):1021–34.

    Article  CAS  Google Scholar 

  28. Gray R, Rajan AS, Radcliffe KA, Yakeiro M, Dani JA. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 1996;383:713–6.

    Article  CAS  PubMed  Google Scholar 

  29. Von Euler US, Gaddum JH. An unidentified depressor substance in certain tissue extracts. J Physiol. 1931;72(1):74–87.

    Article  Google Scholar 

  30. Massoni E, Bersani G. Possibile ruolo della sostanza P e del suo recettore NK1 nei disturbi dell’umore ed in condizioni psichiatriche. Riv Psichiatr. 2003;38(6):289–95.

    Google Scholar 

  31. Sergeyev V, Hokfelt T, Hurd Y. Serotonin and substance P co-exist in dorsal raphe neurons of the human brain. Neuroreport. 1999;10:3967–70.

    Article  CAS  PubMed  Google Scholar 

  32. Roberts GW, et al. Peptides, the limbic lobe and schizophrenia. Brain Res. 1983;288:199–211.

    Article  CAS  PubMed  Google Scholar 

  33. Tezzon Frediano (Head Neurologist, Merano General Hospital). Comment on re-reading this chapter (in the text). March 2016.

    Google Scholar 

  34. Bellucci G. Storia dell’Anestesiologia. Padova: Piccin Editore; 1982. p. 389–92.

    Google Scholar 

  35. Bondy B, Baghai TC, et al. Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry. 2003;53(6):538–42.

    Article  CAS  PubMed  Google Scholar 

  36. Keller M, Montgomery S. Lack of efficacy of the substance P (Neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol Psychiatry. 2006;59:216–23.

    Article  CAS  PubMed  Google Scholar 

  37. Stout SC, Owens MJ, Nemeroff CB. Neurokinin (1) receptor antagonists as potential antidepressant. Ann Rev Pharmacol Toxicol. 2001;41:877–906.

    Article  CAS  Google Scholar 

  38. Nemeroff CB, Widerlov E, Bisette G, Nemeroff CB. Elevated concentrations of CSF corticotropin releasing factor-like immunoreactivity in depressed patients. Science. 1984;22:1343–4.

    Google Scholar 

  39. Galeno di Pergamo, De Tumoribus. Citato in: Cosmacini G, Sironi VA. Il male del secolo, per una storia del cancro. Roma-Bari: Laterza Editore; 2002.

    Google Scholar 

  40. Sirtori C. Atti del “Symposium Cancro del Polmone”. Introduzione biologica generale. Milano, Ospedale Maggiore “Ca Granda”, 22 giugno 1968.

    Google Scholar 

  41. Laborit H. Elogio della fuga. Milano: Mondadori; 1982.

    Google Scholar 

  42. Laborit H. La colombe assasinée. Paris: Editions Grusset & Fasquelle; 1983.

    Google Scholar 

Further Reading

  • Axelsson K, Gupta A. Local anaesthetic adjuvants: neuraxial versus peripheral nerve blocks. Curr Opin Anaesthesiol. 2009;22:649–54.

    Article  PubMed  Google Scholar 

  • Bear MF, Connors BW, Paradiso MA. Neuroscienze: Esplorando il cervello. Milano: Elsevier – Masson; 2009.

    Google Scholar 

  • Brown JL, et al. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol. 1995;356:327–44.

    Article  CAS  PubMed  Google Scholar 

  • Bymaster FP, Carter PA, Yamada M, et al. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci. 2003;17:1403–10.

    Article  PubMed  Google Scholar 

  • Frotscher M, Leranth C. Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry; a combined light and electron microscopic study. J Comp Neurol. 1985;239:237–46.

    Article  CAS  PubMed  Google Scholar 

  • Galzigna L. Il Cervello dell’Uomo. Ferrara: Corso Editore; 1976.

    Google Scholar 

  • Gillespie CF, Nemeroff CB. Hypercortisolemia and depression psychosomatic medicine. J Biobehav Med. 2005;67:S26–8.

    Google Scholar 

  • Gozzano M. Compendio di psichiatria. Torino: Rosenberg & Sellier; 1964.

    Google Scholar 

  • Heim C, Newport DJ, Bonsall R, Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am J Psychiatry. 2001;158:575–81.

    Article  CAS  PubMed  Google Scholar 

  • Hood DD, Eisenach JC, Tuttle RRN. Phase I. Safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology. 1995;82:331–43.

    Article  CAS  PubMed  Google Scholar 

  • http://www.my-personaltrainer.it/vitamina-c.html#3

  • Kramer MS, Winokur A, et al. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004;29(2):385–92.

    Article  CAS  PubMed  Google Scholar 

  • Labrie V, Fukumura R, Rastogi A, et al. Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet. 2009;18:3227–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lewis DA, Fashimoto T, Volk DW. Cortical inhibitory neurons and schizophrenia. Nat Rev. Neurosci. 2005;6:312–24.

    Article  CAS  PubMed  Google Scholar 

  • Morita Y, Ujike H, Tanaka Y, Otani K, et al. A genetic variant of serine racemase gene is associated with schizophrenia. Biol Psychiatry. 2006;61:1200–3.

    Article  PubMed  CAS  Google Scholar 

  • Murphy DB, McCartney CJ, Chan VW. Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth Analg. 2000;90:1122–8.

    Article  CAS  PubMed  Google Scholar 

  • Schwarz MJ, Ackenheil M. The role of substance P in depression. Dialogues Clin Neurosci. 2002;4(1):21–9.

    PubMed  PubMed Central  Google Scholar 

  • Spokes EG. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post- mortem brain tissue. Brain. 1979;102:333–46.

    Article  CAS  PubMed  Google Scholar 

  • Toru M, et al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand. 1988;78:121–37.

    Article  CAS  PubMed  Google Scholar 

  • Kramer MS, Winokur A, et al. Demonstration of the efficacy and safety of a novel substance P (NK 1) receptor antagonist in major depression. Neuropsychopharmacology. 2004;29:385–92.

    Article  CAS  PubMed  Google Scholar 

  • Wolosker H, Blackshaw S, Snyder SH. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Sci U S A. 1999;96:13409–14.

    Article  CAS  Google Scholar 

  • www.psicologi-italia.it/.../depressione/1081/depressione-serotonina.html

    Google Scholar 

  • Yaksh TI, Dirksen R, Haty GJ. Antinoceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol. 1985;117:81–8.

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Behrens MM, Lisman JE. Prolonged exposure to NMDA antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol. 2008;100:959–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Alemanno, F., Alemanno, F. (2020). When the Mind Does Not Work as It Should. In: Alemanno, F. (eds) Biochemistry for Anesthesiologists and Intensivists. Springer, Cham. https://doi.org/10.1007/978-3-030-26721-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-26721-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-26720-9

  • Online ISBN: 978-3-030-26721-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics